top of page
image1.jpg

"Phi Med Europe S.L.'s strengths in research, innovation, development, industrialization, allow us to produce and provide medical devices to improve the monitoring and early diagnosis of sensory neurological dysfunctions demanded by today's physicians, general practice and patients a like."

Story

Phi Med Europe S.L. is a medical technology company founded in 2009 in Barcelona, Spain.

NerveCheck is a new, innovative and portable medical device to detect an early sensory nerves fibers dysfunction in special Neuropathies of Diabetes Mellitus.

What is NerveCheck Master?

NerveCheck Master is a reliable, non-invasive medical diagnostic technology that quantifies the functional status of small and medium-sized sensory nerve fibers that cannot be assessed by EMG.

We optimize and simplify health activity in hospitals and clinics, improving the diagnostic capacity of professionals with a quantified, safe and immediate diagnosis with NerveCheck.

Characteristics NerveCheck Master

Time
saving

Perform 4 tests in 12 minutes

Economically
affordable

No need for a large investment

Ease of
handling

Immediate
results

Intuitive and without prior training

On screen and downloadable

Quantified
results

Non
invasive

Cutting edge
technology

Scientific
validation

Backed by clinical studies

Fast and comfortable for the patient.

Wireless and requires no calibration

Reliable scientifically validated results

NerveCheck Master, a reliable, quick and easy to use medical technology for diagnosing sensory neuropathy.

Diagnosis: Performing five tests, all tests in one technology; Vibration- Cold-Warm -Heat Pain Test or Warm Test by limit method.

Analysis in real time: Quantifying the patient sensory nerve fibre alteration to diagnose and to follow-up the evolution.

Prevention: Early detecting the neuropathy alteration could avoid and reduce the number of amputations.

NerveCheck Master Qualities

Early detection of sensory nerve fiber injury​​

Effectiveness
of medical diagnosis

Personalized treatment when detecting the altered phenotype

Control of the patient's evolution

Increased adherence to treatment

NerveCheck has been carefully designed to be used in the different Healthcare levels to positively impact in Healthcare outcomes and enhance the patient’s quality of care received. 
 
Combining multiple technologies to perform non-invasive tests with reliable results contrasted and validated in International leader institutions and two times awarded by European Union for innovation and development of a medical device.

What doctors say about NerveCheck...
Click on the image and access the scientific document.

Contact

Alissia Maia

I'm always looking for new and exciting opportunities. Let's connect.

bottom of page